Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 17.2B | 18.8B | 17.5B | 17.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 14.8B | 16.0B | 14.7B | 14.5B |
| Operating income | 1.8B | 2.0B | 2.1B | 2.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 227M | 234M | 274M | 268M |
| Other income expense | — | — | — | — |
| Pretax income | 2.2B | 1.9B | 1.7B | 2.6B |
| Tax provision | 405M | 496M | 385M | 492M |
| Net income | 1.9B | 1.5B | 1.3B | 2.1B |
| Basic EPS | 1.8 | 1.4 | 1.2 | 2.1 |
| Diluted EPS | 1.8 | 1.4 | 1.2 | 2.0 |
| Basic average shares | 997.1M | 999.6M | 998.9M | 998.1M |
| Diluted average shares | 999.5M | 1.0B | 1.0B | 999.1M |
| EBITDA | 3.1B | 3.1B | 3.4B | 3.7B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -114M | -91M | -100M | -106M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |